Will Airline Miles and Hotel Points Be Groupon’s Next Growth Driver?
Groupon has said that its users can now earn airline miles and hotel points from top frequent traveler programs if they use Groupon for local, travel or shopping deals.
All Work
Jon C. Ogg
Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AMD, Apple, Biogen, Capital One, Chipotle Mexican Grill, General Motors and 3M.
13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
Top Analyst Upgrades and Downgrades: Boston Scientific, Cleveland-Cliffs, GE, Hasbro, Illumina, T-Mobile, United Continental, Seagate and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Boston Scientific, Cleveland-Cliffs, GE, Hasbro, Illumina, T-Mobile, United Continental, Seagate.
What Cisco Really Gets With the Acquisition of BroadSoft
Cisco will pay $1.7 billion to acquire BroadSoft, a cloud-based communications software provider. Cisco has now made more than 200 acquisitions in total.
Chicago Fed Shows National Economic Activity Rebounded in September
The Chicago Fed National Activity Index rose more than expected in September due to strength in production-related indicators.
Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More
The top analyst upgrades, downgrades and other research calls from Monday include Biogen, Equifax, Foot Locker, General Electric, NVIDIA, Rio Tinto and Roku.
10 Speculative Analyst Stocks With Huge Potential Upside
Here are 10 highly speculative analyst calls made by various Wall Street and boutique firm analysts with huge upside projections made during the week of October 20, 2017.
10 Harsh Realities GE Shareholders Will Have to Face From 2018 to 2020
Investors who are overweight in GE are not getting to enjoy all the great things happening in the U.S. economy and the rekindled global growth story lately. It's time for those shareholders to accept…
Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More
The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?
Now there is a new FDA approval Gilead's CAR T lymphoma treatment named Yescarta that has created at least some buzz for Gilead.
Jobless Claims Hit Lowest Levels Since 1973
The Labor Department of has reported that the number of Americans filing new unemployment applications fell to the lowest level in 44 years — back to March 31, 1973.
Leading Indicators Post First Drop in Over a Year
The Conference Board's latest U.S. Leading Economic Index showed a decline, a disappointment is in the wake of two hurricanes.
Top Analyst Upgrades and Downgrades: Adobe, Allergan, Amex, Baker Hughes, Nike, Northern Dynasty, Sprint, Wayfair and More
The top analyst upgrades, downgrades and other research calls from Thursday include Adobe, Allergan, American Express, Baker Hughes, Nike, Northern Dynasty Minerals, Sprint and Wayfair.
Forget DJIA 23,000 — Why DJIA 25,000 May Be in the Cards for 2018
The Dow Jones Industrial Average may be an antiquated index, but it is also how the public still mostly judges “the stock market” for its gains and losses. With the Dow having punched through…
Exxon Mobil Expands With Permian Basin Terminal Acquisition
It seems like Exxon Mobil Corp. (NYSE: XOM) is located in just about every major oil and gas effort around the planet. After all, it is the largest American oil and gas company by…
Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?
With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the hood to see what this deal really entails.
Meet the New ETF Using Artificial Intelligence to Pick Stocks to Buy
You have probably heard that there is an exchange traded fund strategy for just about every kind of investing theme or trend. Now there is an ETF launch for investors who want their stocks…
IBM Earnings Dilemma: Are Analysts Missing the Boat After 22 Quarters of Revenue Decline?
The question now is whether the positives at IBM outweigh the negatives. IBM also has disappointed for so long that it's hard to blame analysts who remain negative.
Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher
24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors. It has been almost amazing to see just how many price targets have been…